The evolution of pharma marketing: How to reach consumers in the age of digital health
Pharma brands that fail to evolve risk losing relevance in a world where patients demand more control, transparency, and ...
Marketing1y
Digital Marketing for Biotech Companies: From Clinical Trials to Clicks
Many biotech companies approach marketing as if it were some Field of Dreams-style fantasy world where their science alone would make all their dreams come true. Unfortunately, the biotech industry, ...
Fierce Biotech10d
A look at biotech's biggest money raisers of 2024
For the biotech industry, 2024 meant the return of the venture capital megaround. | This week on "The Top Line," we dig into ...
Yahoo Finance7d
Kelun-Biotech's TROP2 ADC Sacituzumab Tirumotecan (sac-TMT) Approved for Marketing in Second Indication by NMPA for EGFRm NSCLC
CHENGDU, China, March 10, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co ... was approved for marketing by the National Medical Products Administration (NMPA) for the second ...
Zacks Investment Research on MSN10d
Biotech Stocks Roundup: CMRX Up on JAZZ Bid, MRNA Up on Updates & More
Mergers and acquisitions grabbed the spotlight in the biotech sector this week after Jazz Pharmaceuticals JAZZ announced an ...
Fierce Pharma10d
Vertex puts patient’s story at heart of National Kidney Month awareness drive
Rouse had presented with symptoms including intense swelling in her legs that she originally thought could be linked to her ...
Morningstar1mon
LINDIS BIOTECH AND PHARMANOVIA ANNOUNCE EUROPEAN MARKETING AUTHORISATION APPROVAL FOR CATUMAXOMAB, A FIRST-IN-CLASS TREATMENT FOR MALIGNANT ASCITES
Dr. Horst Lindhofer, Chief Executive Officer of Lindis Biotech, added: "We are delighted to receive marketing approval for catumaxomab. The approval highlights its potential to address the ...